Loading...
XSTO
ARJO B
Market cap914mUSD
Apr 22, Last price  
32.08SEK
1D
-2.49%
1Q
-13.95%
IPO
31.75%
Name

Arjo AB (publ)

Chart & Performance

D1W1MN
No data to show
P/E
17.69
P/S
0.78
EPS
1.81
Div Yield, %
2.81%
Shrs. gr., 5y
—
Rev. gr., 5y
4.82%
Revenues
11.29b
+2.84%
7,568,000,0008,115,000,0007,808,000,0007,688,000,0008,217,000,0008,925,000,0009,078,000,0009,070,000,0009,979,000,00010,980,000,00011,292,000,000
Net income
498m
+3.75%
619,000,000307,000,000490,000,000118,000,000296,000,000403,000,000526,000,000742,000,000449,000,000480,000,000498,000,000
CFO
2.06b
0.00%
959,000,000811,000,000919,000,000572,000,000991,000,0001,252,000,0002,267,000,0001,734,000,000915,000,0002,061,000,0002,061,000,000
Dividend
Apr 30, 20250.95 SEK/sh
Earnings
Jul 10, 2025

Profile

Arjo AB (publ) develops and sells medical devices and solutions for patients with reduced mobility and age-related health challenges in North America, Western Europe, and internationally. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, treatment and prevention of pressure injuries and leg ulcers, prevention of deep vein thrombosis, treatment of edema, and for obstetric and cardiac diagnostics. The company also provides dementia and bariatric room assessment solutions, as well as clinical consulting, maintenance, and equipment rental and financing solutions. It serves private and public institutions that provide acute and long-term care. The company was founded in 1957 and is headquartered in Malmö, Sweden.
URL
https://www.arjo.com/
IPO date
Dec 12, 2017
Employees
6,800
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
11,292,000
2.84%
10,980,000
10.03%
9,979,000
10.02%
Cost of revenue
10,283,000
10,041,000
9,181,000
Unusual Expense (Income)
NOPBT
1,009,000
939,000
798,000
NOPBT Margin
8.94%
8.55%
8.00%
Operating Taxes
187,000
160,000
149,000
Tax Rate
18.53%
17.04%
18.67%
NOPAT
822,000
779,000
649,000
Net income
498,000
3.75%
480,000
6.90%
449,000
-39.49%
Dividends
(232,000)
(232,000)
(313,000)
Dividend yield
2.35%
2.16%
2.95%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
428,000
2,299,000
2,681,000
Long-term debt
2,130,000
4,348,000
4,800,000
Deferred revenue
559,000
98,000
Other long-term liabilities
2,546,000
659,000
(2,000)
Net debt
1,666,000
5,165,000
6,011,000
Cash flow
Cash from operating activities
2,061,000
2,061,000
915,000
CAPEX
(403,000)
(900,000)
Cash from investing activities
(637,000)
(638,000)
(902,000)
Cash from financing activities
(1,427,000)
(1,427,000)
136,000
FCF
2,179,000
1,559,000
(409,000)
Balance
Cash
892,000
923,000
949,000
Long term investments
559,000
521,000
Excess cash
327,400
933,000
971,050
Stockholders' equity
6,531,000
7,582,000
7,624,000
Invested Capital
11,835,600
12,794,000
12,955,950
ROIC
6.67%
6.05%
5.30%
ROCE
8.30%
6.75%
5.65%
EV
Common stock shares outstanding
272,370
272,370
272,370
Price
36.26
-7.97%
39.40
1.18%
38.94
-64.86%
Market cap
9,876,136
-7.97%
10,731,361
1.18%
10,606,071
-64.86%
EV
11,542,136
15,896,361
16,617,071
EBITDA
2,071,000
1,999,000
1,875,000
EV/EBITDA
5.57
7.95
8.86
Interest
267,000
115,000
Interest/NOPBT
28.43%
14.41%